Search hospitals > Illinois > Evanston
Northshore University HealthSystem
Claim this profileEvanston, Illinois 60201
Global Leader in Prostate Cancer
Global Leader in Breast Cancer
Conducts research for Atopic Dermatitis
Conducts research for Eczema
Conducts research for Psoriasis
342 reported clinical trials
38 medical researchers
Summary
Northshore University HealthSystem is a medical facility located in Evanston, Illinois. This center is recognized for care of Prostate Cancer, Breast Cancer, Atopic Dermatitis, Eczema, Psoriasis and other specialties. Northshore University HealthSystem is involved with conducting 342 clinical trials across 459 conditions. There are 38 research doctors associated with this hospital, such as Nirav Shah, MD, Bruce E. Brockstein, Mary T Jenkins Vogel, MD, and Liana Katz Billings.Area of expertise
1Prostate Cancer
Global LeaderStage IV
2Breast Cancer
Global LeaderStage III
HER2 negative
ER negative
Top PIs
Nirav Shah, MDNorthShore Medical Group4 years of reported clinical research
Studies Coronavirus
Studies Lymphoma
14 reported clinical trials
19 drugs studied
Bruce E. BrocksteinNorthShore University HealthSystem-Evanston Hospital3 years of reported clinical research
Studies Glioblastoma
Studies Skin Cancer
11 reported clinical trials
21 drugs studied
Mary T Jenkins Vogel, MDNorthShore University HealthSystem-Evanston Hospital5 years of reported clinical research
Studies Cancer
Studies Adenocarcinoma
11 reported clinical trials
23 drugs studied
Liana Katz BillingsNorthShore University HealthSystem4 years of reported clinical research
Studies Osteoarthritis
Studies Neuralgia
9 reported clinical trials
13 drugs studied
Clinical Trials running at Northshore University HealthSystem
Breast Cancer
Deep Vein Thrombosis
Obesity
Atopic Dermatitis
Blood Clot
Heart Failure
Gastric Cancer
Type 2 Diabetes
Alopecia Areata
Esophageal Adenocarcinoma
PF-07220060 + Fulvestrant
for Advanced Breast Cancer
The purpose of this study is to learn about the safety and how effective the study medicine (PF-07220060) plus fulvestrant is compared to the study doctor's choice of treatment in people with advanced or metastatic breast cancer. Advanced cancer is the one that is unlikely to be cured or taken care of with treatment. Metastatic cancer is the one that has spread to other parts of the body. This study is seeking female and male participants who: * are 18 years of age or older; * are hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative; * have advanced or metastatic breast cancer after taking other treatments before this study; * have not taken or need to take medications that are not allowed by the study protocol; * do not have any medical or mental conditions that may increase the risk of study participation. Half of the participants will take PF-07220060 two times daily by mouth along with fulvestrant. Fulvestrant will be given as a shot into the muscle. The other half will take the study doctor's choice of treatment which can either be: * Fulvestrant alone taken as shot into the muscle. * Everolimus along with exemestane taken once daily by mouth. This study will compare the experiences of participants receiving the study medicine plus fulvestrant to those who are receiving the study doctor's choice of treatment. This will help decide if the study medicine is safe and effective. Participants will receive study treatment and/or will be in the study until: * imaging scans (such as an MRI and/or CT) show that their cancer is getting worse. * the study doctor thinks the participant is no longer benefitting from the study medicine. * has side effects that become too severe. A side effect is a reaction (expected or unexpected) to a medicine or treatment you take. * the participant chooses to stop taking part.
Recruiting2 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Robotic vs. Open Mastectomy
for Breast Cancer
This trial compares the safety and effectiveness of a new robotic surgery tool, the da Vinci SP Surgical System, to traditional open surgery for patients undergoing breast surgery that spares the nipple. The robotic system aims to improve precision and recovery. The da Vinci SP Surgical System is one of the latest versions of robotic surgery systems, designed for minimally invasive procedures.
Recruiting1 award N/A6 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Northshore University HealthSystem?
Northshore University HealthSystem is a medical facility located in Evanston, Illinois. This center is recognized for care of Prostate Cancer, Breast Cancer, Atopic Dermatitis, Eczema, Psoriasis and other specialties. Northshore University HealthSystem is involved with conducting 342 clinical trials across 459 conditions. There are 38 research doctors associated with this hospital, such as Nirav Shah, MD, Bruce E. Brockstein, Mary T Jenkins Vogel, MD, and Liana Katz Billings.
Where is Northshore University HealthSystem located?
NorthShore University HealthSystem, located at 2650 Ridge Ave, Evanston, IL 60201, offers comprehensive healthcare services. For directions, take the I-94 W and US-41 N to Sheridan Rd in Wilmette, then follow Sheridan Rd to Ridge Ave in Evanston.
Who should I call to ask about financial aid or insurance network?
For billing and insurance inquiries at NorthShore University HealthSystem, contact the Billing, Payment & Insurance department at 888-527-1968. For questions about hospital charges and financial assistance, reach out to the Financial Assistance department at 847.982.3924. Financial counselors are available at each hospital and many medical office sites to assist patients with limited financial resources or limited health coverage.
What insurance does Northshore University HealthSystem accept?
NorthShore University HealthSystem accepts a wide range of insurance plans, including Medicare, Medicaid, Family Health Plans (FHP), Integrated Care Plans (ICP), Medicare-Medicaid Alignment Initiative (MMAI) plans, and TriCare Military Services. They also accept many commercial insurance plans, such as Aetna, Ambetter, and BCBS-IL, along with most employer-offered health insurance plans. It is important to verify coverage and confirm participation with your insurance company for all services.
What awards or recognition has Northshore University HealthSystem received?
NorthShore University HealthSystem, located in Evanston, Illinois, is renowned for its outstanding healthcare services, consistently outperforming peer institutions. It boasts a comprehensive research institute with a strong focus on various medical conditions, supported by millions in external funding, including competitive grants from the National Institutes of Health.